Nexus Pharmaceuticals is pleased to announce the company has ranked #574 in Inc. 5000’s Fastest-Growing Private Companies in America in 2019.
Since inception in 2003, and the launch of its first injectable drug in 2017, Nexus Pharmaceuticals has experienced tremendous growth as a company. By focusing on difficult-to-manufacture sterile injectables, Nexus Pharmaceuticals’ ability to deliver when others fall short has helped mitigate supply disruptions and shortages of life-saving medication in hospitals and health systems.
Nexus also ranked #48 in Top Health Companies, #27 in Top Chicago Companies and #29 in Top Illinois Companies.
Read more on the company’s profile here.
